Skip to main content
Log in

Interactions of Δ11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography

  • Specialia
  • Published:
Experientia Aims and scope Submit manuscript

Summary

Oral administration to man of 20 mgΔ 11-tetrahydrocannabinol (THC) together with placebo or 40 mg cannabinol (CBN) or 40 mg cannabidiol (CBD) gave evidence of a possible limited interaction of THC with CBN but not with CBD as indicated by average plasma THC levels. Peak CBD and CBN concentrations were similar to that of THC, viz. about 5–8 ng/ml.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. G. Nahas and W. Paton, eds, Marihuana: Biological Effects. Pergamon Press, Oxford 1979.

    Google Scholar 

  2. L. Hollister, Experientia29, 825 (1973).

    Article  CAS  PubMed  Google Scholar 

  3. M. Perez-Reyes, M. C. Timmons, K. H. Davis and M. E. Wall, Experientia29, 1368 (1973).

    Article  CAS  PubMed  Google Scholar 

  4. L. Hollister and H. Gillespie, Clin. Pharmac. Ther.18, 80 (1975).

    Article  CAS  Google Scholar 

  5. H. Borys and R. Karler, Biochem. Pharmac.28, 1553 (1979).

    Article  CAS  Google Scholar 

  6. L. Lemberger, B. Dalton, R. Martz, B. Rodda and R. Farney, Ann. N.Y. Acad. Sci.281, 219 (1976).

    Article  CAS  PubMed  Google Scholar 

  7. I. Karniol, I. Shirakawa, N. Kasinski, A. Pfeferman and E. Carlini, Eur. J. Pharm.28, 172 (1974).

    Article  CAS  Google Scholar 

  8. R. Musty, T. Karniol, I. Shirakawa, R. Takahashi and E. Knobel, in: Pharmacology of Marihuana, p. 559. Ed. M. C. Braude and S. Szara, Raven Press, New York 1976.

    Google Scholar 

  9. A. Ohlsson, J. E. Lindgren, K. Leander and S. Agurell, in: Cannabinoid Assays in Humans; NIDA Research Monograph 7, p. 48. Ed. R. Willette. National Institute on Drug Abuse, Rockville 1976.

    Google Scholar 

  10. A. Ohlsson, J. E. Lindgren, A. Wahlén, S. Agurell, L. E. Hollister and H. K. Gillespie, Clin. Pharmac. Ther.28, 409 (1980).

    Article  CAS  Google Scholar 

  11. A. Ohlsson, J. E. Lindgren, K. Leander and S. Agurell, in: Mass spectrometry in drug metabolism, p. 429. Ed. A. Frigerio and E. L. Ghisalberti. Plenum Press, New York 1977.

    Chapter  Google Scholar 

  12. M. Wall, D. Brine and M. Perez-Reyes, in: Pharmacology of Marihuana, p. 93. Ed. M. C. Braude and S. Szara. Raven Press, New York 1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Swedish Medical Research Council and grant MH-00424 from the Veterans Administration.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agurell, S., Carlsson, S., Lindgren, J.E. et al. Interactions of Δ11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 37, 1090–1092 (1981). https://doi.org/10.1007/BF02085029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02085029

Keywords

Navigation